Mingwei Fu

机构：Chinese Academy of Social Sciences, Southwest Petroleum University, Chinese Academy of Medical Sciences & Peking Union Medical College, Zhujiang Hospital, Institute of Hematology & Blood Diseases Hospital, Institute of Economics

发表论文 69 篇 · 总被引 942 次 · h-index 13

代表论文

• Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome (2023 · Cardiovascular Research · 被引 65)
• The metabolite alpha-ketoglutarate inhibits vascular calcification partially through modulation of the TET2/NLRP3 inflammasome signaling pathway (2025 · Kidney International · 被引 17)
• Chemically induced degradation of PRC2 complex by EZH2-Targeted PROTACs via a Ubiquitin-Proteasome pathway (2024 · Bioorganic & Medicinal Chemistry Letters · 被引 8)
• Study of the Polymorphic Transformation Mechanism and Crystal Habits Control of Peramivir from Dihydrate to Trihydrate (2024 · Crystal Growth & Design · 被引 7)
• Comparing Microcrystal Electron Diffraction (MicroED) and X-ray crystallography as methods for structure determination of Oseltamivir phosphate (2024 · Journal of Molecular Structure · 被引 4)
• Correlation between the expression of soluble BCMA and short-term/long-term curative effect and survival outcomes of anti-BCMA CAR-T cell therapy in relapsed/refractory multiple myeloma (2025 · Cell Transplantation · 被引 3)